mit-tech-review
PublishedJuly 27, 2026 at 11:40 AM
—neutral
Closing the data loop in AI-driven drug discovery

Publisher summary· verbatim
Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law. Today, bringing a new drug
Stay posted· Newsletter
A 5-min weekly brief — top movers, price watch, story of the week.
Discussion
No replies yet. Be first.
The Bubble Brief
WEEKLYRead AI insights every Tuesday — top movers, new releases, story of the week.
Originally published on mit-tech-review ↗